DK1511718T3 - N-acylaminobenzenderivater som selektive monoaminoxidase B-inhibitorer - Google Patents

N-acylaminobenzenderivater som selektive monoaminoxidase B-inhibitorer

Info

Publication number: DK1511718T3
Authority: DK; Denmark
Prior art keywords: acylaminobenzene; inhibitors; derivatives; monoamine oxidase; selective monoamine
Prior art date: 2002-05-29

Application number

DK03730080T

Other languages

English (en)

Inventor

Sarmiento Rosa Maria Rodriguez

Synese Jolidon

Andrew William Thomas

Rene Wyler

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-29

Filing date

2003-05-20

Publication date

2009-06-22

2003-05-20 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2009-06-22 Application granted granted Critical

2009-06-22 Publication of DK1511718T3 publication Critical patent/DK1511718T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
- C07C233/15—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
- C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/60—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/16—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/10—Hydrazines
- C07C243/12—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
- C07C243/14—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms of a saturated carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C243/28—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/23—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same unsaturated acyclic carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
- C07C255/25—Aminoacetonitriles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Psychology (AREA)
Rheumatology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK03730080T 2002-05-29 2003-05-20 N-acylaminobenzenderivater som selektive monoaminoxidase B-inhibitorer DK1511718T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP02011639		2002-05-29
PCT/EP2003/005297 WO2003099763A1 (en)	2002-05-29	2003-05-20	N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors

Publications (1)

Publication Number	Publication Date
DK1511718T3 true DK1511718T3 (da)	2009-06-22

Family

ID=29558293

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03730080T DK1511718T3 (da)	2002-05-29	2003-05-20	N-acylaminobenzenderivater som selektive monoaminoxidase B-inhibitorer

Country Status (36)

Country	Link
US (3)	US6762320B2 (da)
EP (1)	EP1511718B1 (da)
JP (1)	JP4223003B2 (da)
KR (1)	KR100706739B1 (da)
CN (1)	CN100482638C (da)
AR (1)	AR040133A1 (da)
AT (1)	ATE430726T1 (da)
AU (1)	AU2003240681B2 (da)
BR (1)	BR0311338A (da)
CA (1)	CA2486380C (da)
CY (1)	CY1109220T1 (da)
DE (1)	DE60327522D1 (da)
DK (1)	DK1511718T3 (da)
EA (1)	EA009372B1 (da)
ES (1)	ES2324214T3 (da)
GT (1)	GT200300119A (da)
HK (1)	HK1081529A1 (da)
HR (1)	HRP20041087B1 (da)
IL (1)	IL165055A0 (da)
MA (1)	MA27208A1 (da)
MX (1)	MXPA04011594A (da)
MY (1)	MY139027A (da)
NO (1)	NO329387B1 (da)
NZ (1)	NZ536538A (da)
PA (1)	PA8574401A1 (da)
PE (1)	PE20040520A1 (da)
PL (1)	PL212708B1 (da)
PT (1)	PT1511718E (da)
RS (1)	RS51642B (da)
SI (1)	SI1511718T1 (da)
TN (1)	TNSN04234A1 (da)
TW (2)	TWI331917B (da)
UA (1)	UA79284C2 (da)
UY (1)	UY27825A1 (da)
WO (1)	WO2003099763A1 (da)
ZA (1)	ZA200408965B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4223003B2 (ja) *	2002-05-29	2009-02-12	エフ．ホフマン−ラロシュアーゲー	選択的モノアミンオキシダーゼｂインヒビターとしてのｎ−アシルアミノベンゼン誘導体
WO2005012280A1 (en) *	2003-07-21	2005-02-10	Applied Research Systems Ars Holding N.V.	Alkynyl aryl carboxamides
US20050089559A1 (en) *	2003-10-23	2005-04-28	Istvan Szelenyi	Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
DE602004017206D1 (de) *	2003-10-23	2008-11-27	Hoffmann La Roche	Benzazepin-derivate als mao-b-hemmer
EP1588704A1 (en)	2004-04-22	2005-10-26	Newron Pharmaceuticals S.p.A.	Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
UA89503C2 (uk) *	2004-09-13	2010-02-10	Х. Луннбек А/С	Заміщені похідні аніліну
US7211573B2 (en) *	2004-12-08	2007-05-01	Hoffmann-La Roche Inc.	Malonamide derivatives
EP2281556A1 (en)	2005-02-25	2011-02-09	F. Hoffmann-La Roche AG	Tablets with improved drugs substance dispersibility
WO2007008963A1 (en) *	2005-07-13	2007-01-18	Jenrin Discovery	Mao-b inhibitors useful for treating obesity
US8722929B2 (en) *	2006-10-10	2014-05-13	Valeant Pharmaceuticals International	N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
US8563566B2 (en) *	2007-08-01	2013-10-22	Valeant Pharmaceuticals International	Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) *	2007-08-13	2010-08-31	Valeant Pharmaceuticals International	Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
MX2010014461A (es) *	2008-06-24	2011-04-28	Valeant Pharmaceuticals Int	Derivados de benciloxi anilida utiles como moduladores de canales de potasio.
US9006371B1 (en) *	2010-09-28	2015-04-14	United States Of America As Represented By The Secretary Of The Navy	Synthesis of oligomeric silsesquioxane monomers for high performance polymers
IT1404729B1 (it) *	2011-01-27	2013-11-29	Univ Pisa	Inibitori altamente selettivi dell'attivita' di adams
CA2826034A1 (en)	2011-01-28	2012-08-02	University Of Kentucky Research Foundation	Stilbene analogs and methods of treating cancer
CN105237567B (zh) *	2015-11-09	2017-09-29	河北工业大学	一种含芳甲基膦酸酯的制备方法
CA3193132A1 (en)	2020-09-03	2022-03-10	Amgen Inc.	Diol desymmetrization by nucleophilic aromatic substitution

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1003753B (de) *	1953-11-07	1957-03-07	Dr Karl Kindler	Verfahren zur Herstellung von N-Dialkylaminoacylaminophenolaethern
JPH05262718A (ja) *	1992-03-23	1993-10-12	Taisho Pharmaceut Co Ltd	５−置換アミノ−２−フェノキシスルホンアニリド化合物
GB9313365D0 (en) *	1993-06-29	1993-08-11	Roussel Lab Ltd	Chemical compounds
US5679715A (en)	1995-06-07	1997-10-21	Harris; Richard Y.	Method for treating multiple sclerosis
AU709323B2 (en)	1996-03-15	1999-08-26	Somerset Pharmaceuticals, Inc.	Method for preventing and treating peripheral neuropathy by administering selegiline
WO2001034172A2 (en)	1999-11-05	2001-05-17	Vela Pharmaceuticals Inc.	Methods and compositions for treating reward deficiency syndrome
JP4223003B2 (ja) *	2002-05-29	2009-02-12	エフ．ホフマン−ラロシュアーゲー	選択的モノアミンオキシダーゼｂインヒビターとしてのｎ−アシルアミノベンゼン誘導体

2003
- 2003-05-20 JP JP2004507421A patent/JP4223003B2/ja not_active Expired - Fee Related
- 2003-05-20 BR BR0311338-8A patent/BR0311338A/pt not_active IP Right Cessation
- 2003-05-20 AU AU2003240681A patent/AU2003240681B2/en not_active Ceased
- 2003-05-20 CA CA2486380A patent/CA2486380C/en not_active Expired - Fee Related
- 2003-05-20 PL PL375311A patent/PL212708B1/pl not_active IP Right Cessation
- 2003-05-20 AT AT03730080T patent/ATE430726T1/de active
- 2003-05-20 DE DE60327522T patent/DE60327522D1/de not_active Expired - Lifetime
- 2003-05-20 NZ NZ536538A patent/NZ536538A/en not_active IP Right Cessation
- 2003-05-20 DK DK03730080T patent/DK1511718T3/da active
- 2003-05-20 EP EP03730080A patent/EP1511718B1/en not_active Expired - Lifetime
- 2003-05-20 SI SI200331610T patent/SI1511718T1/sl unknown
- 2003-05-20 WO PCT/EP2003/005297 patent/WO2003099763A1/en active Application Filing
- 2003-05-20 PT PT03730080T patent/PT1511718E/pt unknown
- 2003-05-20 EA EA200401519A patent/EA009372B1/ru not_active IP Right Cessation
- 2003-05-20 ES ES03730080T patent/ES2324214T3/es not_active Expired - Lifetime
- 2003-05-20 MX MXPA04011594A patent/MXPA04011594A/es active IP Right Grant
- 2003-05-20 CN CNB038123932A patent/CN100482638C/zh not_active Expired - Fee Related
- 2003-05-21 RS YU101204A patent/RS51642B/en unknown
- 2003-05-21 UA UA20041210080A patent/UA79284C2/uk unknown
- 2003-05-21 KR KR1020047019240A patent/KR100706739B1/ko not_active IP Right Cessation
- 2003-05-26 TW TW092114175A patent/TWI331917B/zh not_active IP Right Cessation
- 2003-05-26 PA PA20038574401A patent/PA8574401A1/es unknown
- 2003-05-26 PE PE2003000507A patent/PE20040520A1/es not_active Application Discontinuation
- 2003-05-26 TW TW099119340A patent/TWI340641B/zh not_active IP Right Cessation
- 2003-05-27 UY UY27825A patent/UY27825A1/es not_active Application Discontinuation
- 2003-05-27 US US10/445,580 patent/US6762320B2/en not_active Expired - Lifetime
- 2003-05-28 GT GT200300119A patent/GT200300119A/es unknown
- 2003-05-28 MY MYPI20031959A patent/MY139027A/en unknown
- 2003-05-28 AR ARP030101862A patent/AR040133A1/es not_active Application Discontinuation
2004
- 2004-05-05 US US10/839,514 patent/US7053245B2/en not_active Expired - Fee Related
- 2004-11-04 NO NO20044806A patent/NO329387B1/no not_active IP Right Cessation
- 2004-11-04 IL IL16505504A patent/IL165055A0/xx not_active IP Right Cessation
- 2004-11-05 ZA ZA200408965A patent/ZA200408965B/en unknown
- 2004-11-18 HR HRP20041087AA patent/HRP20041087B1/hr not_active IP Right Cessation
- 2004-11-24 TN TNP2004000234A patent/TNSN04234A1/fr unknown
- 2004-11-26 MA MA27971A patent/MA27208A1/fr unknown
2005
- 2005-08-26 US US11/213,052 patent/US20050283019A1/en not_active Abandoned
2006
- 2006-02-10 HK HK06101769.1A patent/HK1081529A1/xx not_active IP Right Cessation
2009
- 2009-07-10 CY CY20091100728T patent/CY1109220T1/el unknown

Also Published As

Publication number	Publication date
BR0311338A (pt)	2005-03-22
TW201036607A (en)	2010-10-16
AU2003240681B2 (en)	2008-10-09
NO329387B1 (no)	2010-10-11
MXPA04011594A (es)	2005-03-07
US7053245B2 (en)	2006-05-30
US20030232883A1 (en)	2003-12-18
EP1511718B1 (en)	2009-05-06
CY1109220T1 (el)	2014-07-02
PA8574401A1 (es)	2003-12-19
PT1511718E (pt)	2009-06-12
EP1511718A1 (en)	2005-03-09
TWI331917B (en)	2010-10-21
RS51642B (en)	2011-10-31
US20050283019A1 (en)	2005-12-22
ATE430726T1 (de)	2009-05-15
ZA200408965B (en)	2006-06-28
AR040133A1 (es)	2005-03-16
TNSN04234A1 (fr)	2007-03-12
PL375311A1 (en)	2005-11-28
EA200401519A1 (ru)	2005-06-30
NZ536538A (en)	2007-08-31
HK1081529A1 (en)	2006-05-19
ES2324214T3 (es)	2009-08-03
JP4223003B2 (ja)	2009-02-12
AU2003240681A1 (en)	2003-12-12
JP2005527617A (ja)	2005-09-15
CA2486380C (en)	2011-10-25
UA79284C2 (en)	2007-06-11
US6762320B2 (en)	2004-07-13
EA009372B1 (ru)	2007-12-28
KR20050016460A (ko)	2005-02-21
CN100482638C (zh)	2009-04-29
RS101204A (en)	2007-02-05
KR100706739B1 (ko)	2007-04-11
WO2003099763A1 (en)	2003-12-04
CA2486380A1 (en)	2003-12-04
HRP20041087A2 (en)	2005-06-30
CN1656057A (zh)	2005-08-17
MA27208A1 (fr)	2005-01-03
UY27825A1 (es)	2003-12-31
IL165055A0 (en)	2005-12-18
SI1511718T1 (sl)	2009-08-31
PL212708B1 (pl)	2012-11-30
MY139027A (en)	2009-08-28
US20040210079A1 (en)	2004-10-21
DE60327522D1 (de)	2009-06-18
TW200401632A (en)	2004-02-01
NO20044806L (no)	2004-12-29
GT200300119A (es)	2004-03-15
HRP20041087B1 (hr)	2013-06-30
WO2003099763A8 (en)	2004-03-18
TWI340641B (en)	2011-04-21
PE20040520A1 (es)	2004-08-24

Publication	Publication Date	Title
DK1492785T3 (da)	2009-03-02	2-hydroxy-3-heteroarylindol-derivater som GSK3-inhibitorer
HK1081529A1 (en)	2006-05-19	N-acylaminobenzene derivatives as selective monoamine oxidase b inhibitors
DK1220831T3 (da)	2005-08-29	Biaryletherderivater, der er nyttige som monoamingenoptagelsesinhibitorer
NO20044654L (no)	2004-10-28	Piperidinoylpiperidiner som 5-HTIF-agonister
DK2130537T3 (da)	2013-02-18	N3-alkylerede benzimidazolderivater som MEK-inhibitorer
NO20050665L (no)	2005-04-18	Pyrrolidonderivater som MAOE inhibitoere
DK1789041T3 (da)	2008-09-08	Aryl-pyridinderivater som 11-beta-HSD1-inhibitorer
NO20052887D0 (no)	2005-06-14	Pyridazinonderivater som GSK-3Beta inhibitorer.
NO20030867D0 (no)	2003-02-25	Hydroksamderivater anvendelig som deacetylaseinhibitorer
NO20055680D0 (no)	2005-12-01	Heksahydropyridoisokinoliner som DPP-IV-inhibitorer
NO20043793L (no)	2004-10-21	Nikotinamidderivater anvendelige som PDE4 inhibitorer
DK1501826T3 (da)	2007-01-29	Substituerede indoler som alpha-1-agonister
NO20053356L (no)	2005-07-11	Aminindazolderivater og anvendelse derav som kinaseinhibitorer.
DK1527050T3 (da)	2010-07-19	Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer
NO20053775D0 (no)	2005-08-08	Diazepinoindol derivater som kinaseinhibitorer.
DK1797042T3 (da)	2009-03-02	Indozolonderivater som 11B-HSD1-inhibitorer
NO20034307D0 (no)	2003-09-26	Cyklopropylindol-derivater som selektive serotonin- gjenopptaksinhibitorer
NO20033618L (no)	2003-10-15	Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
NO20051236L (no)	2005-04-08	Heterobiarylderivater som matriksmetalloproteinaseinhibitorer
DK1438289T3 (da)	2005-08-08	Indolderivater som cox II-inhibitorer
DK1556377T3 (da)	2006-10-23	Cyclopropylthienylcarboxamider som fungicider
DK1651641T3 (da)	2007-09-03	Nicotinamidderivater egnede som PDE4 inhibitorer
DK1499622T3 (da)	2009-06-08	Meterotricyclyl-6-alkylidenpenemer som beta-lactamaseinhibitorer
NO20043610L (no)	2004-10-05	Fenylpyrimidinaminer som IgE inhibitorer
DK1487802T3 (da)	2011-04-04	2,3-diaryl-pyrazolidin-derivater som neurotensin-nedbrydende enzyminhibitorer